Smith & Nephew Plc Stock price

Equities

SN.

GB0009223206

Medical Equipment, Supplies & Distribution

Delayed London S.E. 12:35:05 2024-03-28 pm EDT 5-day change 1st Jan Change
991.6 GBX -4.97% Intraday chart for Smith & Nephew Plc -4.01% -8.06%
Sales 2024 * 5.84B Sales 2025 * 6.13B Capitalization 10.93B
Net income 2024 * 554M Net income 2025 * 705M EV / Sales 2024 * 2.32 x
Net Debt 2024 * 2.64B Net Debt 2025 * 2.25B EV / Sales 2025 * 2.15 x
P/E ratio 2024 *
21.8 x
P/E ratio 2025 *
16.1 x
Employees 18,452
Yield 2024 *
3.07%
Yield 2025 *
3.42%
Free-Float 99.15%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Smith & Nephew Plc

1 day-4.97%
1 week-4.01%
Current month-4.70%
1 month-5.43%
3 months-7.89%
6 months-2.35%
Current year-8.06%
More quotes
1 week
991.00
Extreme 991
1 050.00
1 month
991.00
Extreme 991
1 109.00
Current year
991.00
Extreme 991
1 181.50
1 year
887.00
Extreme 887
1 316.75
3 years
887.00
Extreme 887
1 601.50
5 years
887.00
Extreme 887
2 023.00
10 years
858.50
Extreme 858.5
2 023.00
More quotes
Managers TitleAgeSince
Chief Executive Officer - 22-03-31
Director of Finance/CFO 53 20-07-26
Compliance Officer - 99-03-31
Members of the board TitleAgeSince
Director/Board Member 65 17-09-30
Director/Board Member 62 23-09-13
Chairman 63 23-04-25
More insiders
Date Price Change Volume
24-03-28 991.6 -4.97% 6,662,405
24-03-27 1,044 +1.07% 2,367,190
24-03-26 1,032 +1.37% 4,278,595
24-03-25 1,018 -1.97% 2,136,421
24-03-22 1,039 +0.58% 3,340,465

Delayed Quote London S.E., March 28, 2024 at 12:35 pm EDT

More quotes
Smith & Nephew Plc specializes in designing, manufacturing and marketing medical products and equipment. Net sales break down by activity sector as follows: - orthopedic surgery (39.9%): primarily orthopedic implants (hips, knees and shoulders); - sports medicine, arthroscopy and cervicofacial surgery (31.2%): surgery and damaged tissue repair products and instruments, visualization products, etc.; - wound care (28.9%): skin grafts for major burns victims, treatments for leg ulcers, etc. The United States accounts for 53.7% of net sales.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
18
Last Close Price
12.53 USD
Average target price
16.51 USD
Spread / Average Target
+31.75%
Consensus
  1. Stock
  2. Equities
  3. Stock Smith & Nephew Plc - London S.E.